Onconetix, Inc. (ONCO)
NASDAQ: ONCO · Real-Time Price · USD
3.390
+0.200 (6.27%)
At close: Sep 26, 2025, 4:00 PM EDT
3.180
-0.211 (-6.21%)
After-hours: Sep 26, 2025, 7:59 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023
Period Ending
Dec '23
Vaccine Discovery and Development
58.47K

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023
Period Ending
Dec '23
Switzerland
58.47K